Glucose deprivation increases monocarboxylate transporter 1 (MCT1) expression and MCT1-dependent tumor cell migration

Oncogene

Volumn 33, Issue 31, 2014, Pages 4060-4068

  De Saedeleer, C J ^a   Porporato, P E ^a   Copetti, T ^a   Perez Escuredo J ^a   Payen, V L ^a   Brisson, L ^a   Feron, O ^a   Sonveaux, P ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

Basigin; Glucose metabolism; Mitochondrial dysfunction; Monocarboxylate transporter 1 (MCT1); Reactive oxygen species (ROS); Tumor cell migration

Indexed keywords

ACETYLCYSTEINE; ANTIOXIDANT; CD147 ANTIGEN; GLUCOSE; HYDROGEN PEROXIDE; MONOCARBOXYLATE TRANSPORTER 1; REACTIVE OXYGEN METABOLITE; ROTENONE; SUPEROXIDE;

ARTICLE; CELL INTERACTION; CELL MEMBRANE; CELL MIGRATION; COMPLEX FORMATION; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; GENE OVEREXPRESSION; GLUCOSE SENSOR; GLYCOLYSIS; HELA CELL LINE; HUMAN; HUMAN CELL; HYPOXIA; METASTASIS; MITOCHONDRION; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; STARVATION; TUMOR CELL; UPREGULATION;

ANTIGENS, CD147; CELL LINE, TUMOR; CELL MOVEMENT; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLUCOSE; GLYCOLYSIS; HELA CELLS; HUMANS; MITOCHONDRIA; MONOCARBOXYLIC ACID TRANSPORTERS; REACTIVE OXYGEN SPECIES; SYMPORTERS; UTERINE CERVICAL NEOPLASMS;

EID: 84905402353     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2013.454     Document Type: Article

References (49)

1. Porporato PE, Dadhich RK, Dhup S, Copetti T, Sonveaux P. Anticancer targets in the glycolytic metabolism of tumors: a comprehensive review. Front Pharmacol 2011; 2: 49.
2. Dhup S, Dadhich RK, Porporato PE, Sonveaux P. Multiple biological activities of lactic acid in cancer: influences on tumor growth, angiogenesis and metastasis. Curr Pharm Des 2012; 18: 1319-1330.
3. Sonveaux P, Vegran F, Schroeder T, Wergin MC, Verrax J, Rabbani ZN et al. Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice. J Clin Invest 2008; 118: 3930-3942.
4. Dimmer KS, Friedrich B, Lang F, Deitmer JW, Broer S. The low-affinity mono-carboxylate transporter MCT4 is adapted to the export of lactate in highly gly-colytic cells. Biochem J 2000; 350: 219-227.
5. Ullah MS, Davies AJ, Halestrap AP. The plasma membrane lactate transporter MCT4, but not MCT1, is up-regulated by hypoxia through a HIF-1alpha-dependent mechanism. J Biol Chem 2006; 281: 9030-9037.
6. Vegran F, Boidot R, Michiels C, Sonveaux P, Feron O. Lactate influx through the endothelial cell monocarboxylate transporter MCT1 supports an NF-kappaB/IL-8 pathway that drives tumor angiogenesis. Cancer Res 2011; 71: 2550-2560.
7. Sonveaux P, Copetti T, De Saedeleer CJ, Vegran F, Verrax J, Kennedy KM et al. Targeting the lactate transporter MCT1 in endothelial cells inhibits lactate-induced HIF-1 activation and tumor angiogenesis. PLoS ONE 2012; 7: e33418.
8. De Saedeleer CJ, Copetti T, Porporato PE, Verrax J, Feron O, Sonveaux P. Lactate Activates HIF-1 in Oxidative but Not in Warburg-Phenotype Human Tumor Cells. PLoS ONE 2012; 7: e46571.
9. Lu H, Forbes RA, Verma A. Hypoxia-inducible factor 1 activation by aerobic gly-colysis implicates the Warburg effect in carcinogenesis. J Biol Chem 2002; 277: 23111-23115.
10. Walenta S, Mueller-Klieser WF. Lactate: mirror and motor of tumor malignancy. Semin Radiat Oncol 2004; 14: 267-274.
11. Halestrap AP, Wilson MC. The monocarboxylate transporter family-role and regulation. IUBMB Life 2012; 64: 109-119.
12. Asada K, Miyamoto K, Fukutomi T, Tsuda H, Yagi Y, Wakazono K et al. Reduced expression of GNA11 and silencing of MCT1 in human breast cancers. Oncology 2003; 64: 380-388.
13. Kirk P, Wilson MC, Heddle C, Brown MH, Barclay AN, Halestrap AP. CD147 is tightly associated with lactate transporters MCT1 and MCT4 and facilitates their cell surface expression. EMBO J 2000; 19: 3896-3904.
14. Kennedy KM, Dewhirst MW. Tumor metabolism of lactate: the influence and therapeutic potential for MCT and CD147 regulation. Future Oncol 2010; 6: 127-148.
15. Le Floch R, Chiche J, Marchiq I, Naiken T, Ilk K, Murray CM et al. CD147 subunit of lactate/H symporters MCT1 and hypoxia-inducible MCT4 is critical for energetics and growth of glycolytic tumors. Proc Natl Acad Sci USA 2011; 108: 16663-16668.
16. Walenta S, Snyder S, Haroon ZA, Braun RD, Amin K, Brizel D et al. Tissue gradients of energy metabolites mirror oxygen tension gradients in a rat mammary carcinoma model. Int J Radiat Oncol Biol Phys 2001; 51: 840-848.
17. Hirayama A, Kami K, Sugimoto M, Sugawara M, Toki N, Onozuka H et al. Quantitative metabolome profiling of colon and stomach cancer microenvironment by capillary electrophoresis time-of-flight mass spectrometry. Cancer Res 2009; 69: 4918-4925.
18. Reitzer LJ, Wice BM, Kennell D. Evidence that glutamine, not sugar, is the major energy source for cultured HeLa cells. J Biol Chem 1979; 254: 2669-2676.
19. Wu R, Racker E. Regulatory mechanisms in carbohydrate metabolism. IV. Pasteur effect and Crabtree effect in ascites tumor cells. J Biol Chem 1959; 234: 1036-1041.
20. Yun J, Rago C, Cheong I, Pagliarini R, Angenendt P, Rajagopalan H et al. Glucose deprivation contributes to the development of KRAS pathway mutations in tumor cells. Science 2009; 325: 1555-1559.
21. Murphy MP. How mitochondria produce reactive oxygen species. Biochem J 2009; 417: 1-13.
22. Mukhopadhyay P, Rajesh M, Hasko G, Hawkins BJ, Madesh M, Pacher P. Simultaneous detection of apoptosis and mitochondrial superoxide production in live cells by flow cytometry and confocal microscopy. Nat Protoc 2007; 2: 2295-2301.
23. Dikalova AE, Bikineyeva AT, Budzyn K, Nazarewicz RR, McCann L, Lewis W et al. Therapeutic targeting of mitochondrial superoxide in hypertension. Circ Res 2010; 107: 106-116.
24. Schewe T. Molecular actions of ebselen-an antiinflammatory antioxidant. Gen Pharmacol 1995; 26: 1153-1169.
25. Mattila PK, Lappalainen P. Filopodia: molecular architecture and cellular functions. Nat Rev Mol Cell Biol 2008; 9: 446-454.
26. Manning Fox JE, Meredith D, Halestrap AP. Characterisation of human mono-carboxylate transporter 4 substantiates its role in lactic acid efflux from skeletal muscle. J Physiol 2000; 529: 285-293.
27. Wallace DC. Mitochondria and cancer. Nat Rev Cancer 2012; 12: 685-698.
28. Dang CV, Hamaker M, Sun P, Le A, Gao P. Therapeutic targeting of cancer cell metabolism. J Mol Med (Berl) 2011; 89: 205-212.
29. Eyster CA, Higginson JD, Huebner R, Porat-Shliom N, Weigert R, Wu WW et al. Discovery of new cargo proteins that enter cells through clathrin-independent endocytosis. Traffic 2009; 10: 590-599.
30. Smith JP, Uhernik AL, Li L, Liu Z, Drewes LR. Regulation of Mct1 by cAMP-dependent internalization in rat brain endothelial cells. Brain Res 2012; 1480: 1-11.
31. De Bock K, Mazzone M, Carmeliet P. Antiangiogenic therapy, hypoxia, and metastasis: risky liaisons, or not? Nat Rev Clin Oncol 2011; 8: 393-404.
32. Lee GH, Kim DS, Chung MJ, Chae SW, Kim HR, Chae HJ. Lysyl oxidase-like-1 enhances lung metastasis when lactate accumulation and monocarboxylate transporter expression are involved. Oncol Lett 2011; 2: 831-838.
33. Cardaci S, Rizza S, Filomeni G, Bernardini R, Bertocchi F, Mattei M et al. Glutamine deprivation enhances antitumor activity of 3-bromopyruvate through the stabilization of monocarboxylate transporter-1. Cancer Res 2012; 72: 4526-4536.
34. Birsoy K, Wang T, Possemato R, Yilmaz OH, Koch CE, Chen WW et al. MCT1-mediated transport of a toxic molecule is an effective strategy for targeting glycolytic tumors. Nat Genet 2012; 45: 104-108.
35. Ferretti AC, Larocca MC, Favre C. Nutritional stress in eukaryotic cells: oxidative species and regulation of survival in time of scarceness. Mol Genet Metab 2012; 105: 186-192.
36. Jia L, Xu H, Zhao Y, Jiang L, Yu J, Zhang J. Expression of CD147 mediates tumor cells invasion and multidrug resistance in hepatocellular carcinoma. Cancer Invest 2008; 26: 977-983.
37. Izumi H, Takahashi M, Uramoto H, Nakayama Y, Oyama T, Wang KY et al. Monocarboxylate transporters 1 and 4 are involved in the invasion activity of human lung cancer cells. Cancer Sci 2011; 102: 1007-1013.
38. Li J, Peng L, Wu L, Kuang Y, Su J, Yi M et al. Depletion of CD147 sensitizes human malignant melanoma cells to hydrogen peroxide-induced oxidative stress. J Dermatol Sci 2010; 58: 204-210.
39. Iacono KT, Brown AL, Greene MI, Saouaf SJ. CD147 immunoglobulin superfamily receptor function and role in pathology. Exp Mol Pathol 2007; 83: 283-295.
40. Boidot R, Vegran F, Meulle A, Le Breton A, Dessy C, Sonveaux P et al. Regulation of monocarboxylate transporter MCT1 expression by p53 mediates inward and outward lactate fluxes in tumors. Cancer Res 2012; 72: 939-948.
41. Ke X, Fei F, Chen Y, Xu L, Zhang Z, Huang Q et al. Hypoxia upregulates CD147 through a combined effect of HIF-1alpha and Sp1 to promote glycolysis and tumor progression in epithelial solid tumors. Carcinogenesis 2012; 33: 1598-1607.
42. Merezhinskaya N, Fishbein WN. Monocarboxylate transporters: past, present, and future. Histol Histopathol 2009; 24: 243-264.
43. Rademakers SE, Lok J, van der Kogel AJ, Bussink J, Kaanders JH. Metabolic markers in relation to hypoxia; staining patterns and colocalization of pimonidazole, HIF-1alpha, CAIX, LDH-5, GLUT-1, MCT1 and MCT4. BMC Cancer 2011; 11: 167.
44. Cheng C, Edin NF, Lauritzen KH, Aspmodal I, Christoffersen S, Jian L et al. Alterations of monocarboxylate transporter densities during hypoxia in brain and breast tumour cells. Cell Oncol 2012; 35: 217-227.
45. Gallagher SM, Castorino JJ, Philp NJ. Interaction of monocarboxylate transporter 4 with beta1-integrin and its role in cell migration. Am J Physiol Cell Physiol 2009; 296: C414-C421.
46. Stock C, Schwab A. Protons make tumor cells move like clockwork. Pflugers Arch 2009; 458: 981-992.
47. Webb BA, Chimenti M, Jacobson MP, Barber DL. Dysregulated pH: a perfect storm for cancer progression. Nat Rev Cancer 2011; 11: 671-677.
48. Xu D, Hemler ME. Metabolic activation-related CD147-CD98 complex. Mol Cell Proteomics 2005; 4: 1061-1071.
49. Moon EJ, Sonveaux P, Porporato PE, Danhier P, Gallez B, Batinic-Haberle I et al. NADPH oxidase-mediated reactive oxygen species production activates hypoxia-inducible factor-1 (HIF-1) via the ERK pathway after hyperthermia treatment. Proc Natl Acad Sci USA 2010; 107: 20477-20482.